Chinese Journal of Pharmacovigilance ›› 2019, Vol. 16 ›› Issue (9): 566-567.
DOI: 10.19803/j.1672-8629.2019.09.09
Previous Articles Next Articles
WU Qingyun1, PAN Yuhua2, LIANG Huaban3, YE Zhiming3, LAO Haiyan2,*
Received:2019-03-04
Revised:2019-10-21
Online:2019-09-20
Published:2019-10-21
CLC Number:
WU Qingyun, PAN Yuhua, LIANG Huaban, YE Zhiming, LAO Haiyan. One Case of Numbness of Extremities Induced by Cyclosporine Soft Capsules[J]. Chinese Journal of Pharmacovigilance, 2019, 16(9): 566-567.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.zgywjj.com/EN/10.19803/j.1672-8629.2019.09.09
| [1] 程凯, 贾萍, 徐埏, 等. 72例环孢素A所致不良反应文献分析[J].中国药业, 2010, 19(1): 36-37. [2] 常馨予, 郭桂明, 刘洋. 等. 药物相互作用致环孢素不良反应分析及药学监护[J]. 药学实践杂志, 2018,36(4):365-368. [3] Batinić D, Milošević D, Filipović-Grčić B, et al.Neurotoxicity of cyclosporine A in children with steroid-resistant nephrotic syndrome: is cytotoxic edema really an unfavorable predictor of permanent neurological damage?[J]. Wien Klin Wochenschr, 2017, 129(15-16): 579-582. [4] 曲彩红, 苏向阳.伏立康唑致环孢素血药浓度升高相关癫痫样发作[J].药物不良反应杂志, 2010, 12(5): 354-356. [5] 丁春雷, 孙健姿, 张熠, 等. 环孢素浓度异常升高致高尿酸血症1例[J].中国药物警戒, 2011, 8(3):190. [6] da Silva J B, de Melo Lima M H, Secoli S R. Influence of cyclosporine on the occurrence of nephrotoxicity after allogeneichematopoietic stem cell transplantation: a systematic review[J]. Rev Bras Hematol Hemoter, 2014,36(5):363-368. [7] 叶晓兰, 唐崑. 一例环孢素引起外周神经系统损害的病例分析[J]. 上海医药, 2017, 38(5): 57-59. [8] 曾湘豫, 秦斌, 曹国颖, 等. 环孢菌素A血浓度监测对神经系统自身免疫性疾病治疗的意义[J]. 中国神经免疫学和神经病学杂志, 2001, 8(3): 153-156. [9] Yanagimachi M, Naruto T, Tanoshima R, et al.Influence of CYP3A5 and ABCB1 gene polymorphisms on calcineurin inhibitor-related neurotoxicity after hematopoietic stem cell transplantation[J]. Clin Transplant, 2010, 24(6): 855-861. [10] Crettol S, Venetz J P, Fontana M, et al.CYP3A7,CYP3A5,CYP3A4, and ABCB1 genetic polymorphisms, cyclosporine concentration, and dose requirement in transplant recipients[J]. Ther Drug Monit, 2008, 30(6): 689-699. |
| [1] | SUN Qiyue, ZHAO Ronghua, GUO Shanshan, BAO Lei, GENG Zihan, LI Shuran, XU Yingli, ZHANG Jingsheng, CUI Xiaolan, SUN Jing. Multiple pharmacological effects of Lingyang Ganmao Oral Liquid [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 127-131. |
| [2] | ZHAO Ronghua, SUN Jing, BAO Lei, GENG Zihan, TAO Xiali, ZHANG Jingsheng, PANG Bo, XU Yingli, CAO Shan, LI Shuran, GUO Shanshan, WANG Daohan, CUI Xiaolan. Mechanisms of Gegen Tang granules against viral pneumonia in mice based on immune regulation [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 132-136. |
| [3] | BAO Lei, GENG Zihan, LI Shuran, JI Zuen, ZHAO Ronghua, SUN Jing, GUO Shanshan, CUI Xiaolan. The critical role of TRP channels in the progression of viral pneumonia [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 137-140. |
| [4] | JIA Jinsheng, LIU Hongliang, WANG Qing, HOU Yongfang, LI Xinling. Evaluation of the relevance of adverse drug reaction based on ERNIE-DPCNN [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 163-166. |
| [5] | LI Jiaxin, LIU Huimin, QIAN Wenxiu, MA Ning, SONG Lili, LI Yubo. Nephrotoxic effects and usage of traditional Chinese medicines based on the Traditional Chinese Medicine Systems Toxicology Database [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 173-180. |
| [6] | FAN Kaikai, WANG Cong, LIU Hongfeng, WANG Xiyong. Effects of clinical pharmacist interventions on usage of alanyl-glutamine injections in a hospital [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 181-184. |
| [7] | ZHANG Jian, FANG Huihua. Applicability of evaluation standards for use of traditional Chinese medicine injections for promoting blood circulation and removing blood stasis [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 185-189. |
| [8] | WANG Shan, XIE Bo, LIU Huimin, LI Zhihao. Adverse event signals for celecoxib based on FAERS database [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 190-194. |
| [9] | LI Yingfen, HAN Lei. Analysis of 319 cases of adverse drug reaction induced by cerebroprotein hydrolysate for injection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 195-198. |
| [10] | XU Weijia, PENG Qi, HUANG Haiyu, ZHANG Leijiao, XIAO Hua, WU Xue. 285 cases of adverse drug reaction related to new antineoplastic drugs [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 199-203. |
| [11] | GUO Qinghua, PENG Xiaoxiao, ZHU Ping, LIU Xilin, YANG Yinghua, CHEN Zhihai. One case of multiple organ dysfunction syndrome caused by amlodipine overdose [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 204-207. |
| [12] | FANG Meilin, ZHENG Huimin, WANG Cunze, WANG Ling, RUAN Junshan. One case of generalized myalgia caused by oxaliplatin [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 208-210. |
| [13] | LI Na, GUO Jun, GUO Wenjia, LYU Yinyin, LI Caihong, MU Xiangdong. One case of delayed skin allergic reaction caused by asthma treated with omalizumab injection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 211-212. |
| [14] | CAO Guiping, DENG Linlin, ZHU Ganhong, LU Ying, MA Shuang, CHEN Linlin, Liu Lili. One case of severe liver injury caused by Tianma Shouwu tablets [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 216-218. |
| [15] | ZHU Ying, SHEN Lu, LI Lan, WU Jianmin, GAO Xiaojie. Adverse reaction monitoring of toothpaste in China under the new regulatory system [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 219-222. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
